Ledger.Open graph →
SEC Form D · filed April 2, 2018

Twist Bioscience Corp

Offering
$85.0M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Bob M. Ragusa · San Francisco, CADirectorWilliam M. Banyai · San Francisco, CAExec · DirectorPaul M. Conley · San Francisco, CADirectorFred M. Craves · San Francisco, CADirectorRob M. Chess · San Francisco, CADirectorKeith M. Crandell · San Francisco, CADirectorBill M. Peck · San Francisco, CAExecEmily M. Leproust · San Francisco, CAExec · DirectorSam Liebman · New York, NYDirectorBob Nelson · Frisco, TXDirectorJoseph M. Niehaus · San Francisco, CADirectorMinqi M. Li · San Francisco, CADirectorJoe P. Nemeth · Redwood City, CADirectorMichael J. Fourticq, Senior · Houston, TXExec · DirectorWilliam N. Anderson · Houston, TXExec · DirectorBritton L. Brown · Dallas, TXDirectorPeter H. Huizenga · Oak Brook, ILExecMark G. Hilderbrand · San Francisco, CADirectorBarry D. Reynolds · San Francisco, CADirectorLouis A. La Luna · Jamison, PADirectorMinqi M. Li · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗